Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-25-005236
Filing Date
2025-08-08
Accepted
2025-08-08 16:45:54
Documents
60
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q edsa20250630_10q.htm   iXBRL 10-Q 1082149
2 EXHIBIT 31.1 ex_846550.htm EX-31.1 12121
3 EXHIBIT 31.2 ex_846551.htm EX-31.2 12059
4 EXHIBIT 32.1 ex_846552.htm EX-32.1 5090
5 EXHIBIT 32.2 ex_847093.htm EX-32.2 5073
  Complete submission text file 0001171843-25-005236.txt   5320317

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA edsa-20250630.xsd EX-101.SCH 54699
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20250630_def.xml EX-101.DEF 357472
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20250630_lab.xml EX-101.LAB 321936
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20250630_pre.xml EX-101.PRE 386078
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20250630_cal.xml EX-101.CAL 31093
63 EXTRACTED XBRL INSTANCE DOCUMENT edsa20250630_10q_htm.xml XML 803435
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 251199132
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)